down arrow

Corline Biomedical AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0006887451
SEK
17.55
-0.35 (-1.96%)

Jun 25

OME

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Stille AB
Senzime AB
Q-linea AB
Corline Biomedical AB
Promimic AB
Paxman AB
Enzymatica AB
OssDsign AB
Boule Diagnostics AB
Integrum AB
Curasight A/S

Why is Corline Biomedical AB ?

1
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 60.27%, its profits have fallen by -11.4%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Corline Biomedical AB for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Corline Biomedical AB
60.27%
0.99
61.74%
OMX Stockholm 30
30.13%
1.89
15.95%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
15.64%
EBIT Growth (5y)
-51.66%
EBIT to Interest (avg)
-5.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.16
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.00%
ROE (avg)
0.88%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.13
EV to EBIT
-25.77
EV to EBITDA
-25.93
EV to Capital Employed
5.00
EV to Sales
47.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.41%
ROE (Latest)
-15.69%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -61.44% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -32.76 %

INVENTORY TURNOVER RATIO(HY)

Highest at 57.39 times

NET SALES(Q)

Highest at SEK 4.29 MM

OPERATING PROFIT(Q)

Highest at SEK -2.41 MM

OPERATING PROFIT MARGIN(Q)

Highest at -56.14 %

PRE-TAX PROFIT(Q)

Highest at SEK -2.5 MM

NET PROFIT(Q)

Highest at SEK -2.5 MM

EPS(Q)

Highest at SEK -0.1

-4What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at SEK -17.5 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.19 times

Here's what is working for Corline Biomedical AB

Net Sales
At SEK 4.29 MM has Grown at 124.34%
over average net sales of the previous four periods of SEK 1.91 MM
MOJO Watch
Near term sales trend is extremely positive

Net Sales (SEK MM)

Net Sales
Highest at SEK 4.29 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit
Highest at SEK -2.41 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at -56.14 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK -2.5 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Net Profit
Highest at SEK -2.5 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

EPS
Highest at SEK -0.1
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Debt-Equity Ratio
Lowest at -32.76 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio
Highest at 57.39 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -61.44% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Corline Biomedical AB

Operating Cash Flow
Lowest at SEK -17.5 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Debtors Turnover Ratio
Lowest at 2.19 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."